or Try an Advanced Search...

    Technical Analysis for RPTX - Repare Therapeutics Inc.

    Grade Last Price % Change Price Change
    F 3.79 15.55% 0.51
    RPTX closed up 15.55 percent on Wednesday, May 8, 2024, on 23.1 times normal volume.
    2 Watchers
    Watchlist Portfolio

    Trend Table & Recent EOD Trading Signals

    ADX Long Term Intermediate Term Short Term
    Strong Down Down Up
    Historical RPTX trend table...
    Date Alert Name Type % Chg
    Crossed Above 20 DMA Bullish 0.00%
    New Uptrend Bullish 0.00%
    Pocket Pivot Bullish Swing Setup 0.00%
    Volume Surge Other 0.00%
    Bollinger Band Squeeze Range Contraction 0.00%
    Earnings Movers Other 0.00%
    BB Squeeze + Upper Band Touch Range Contraction 0.00%
    BB Squeeze Started Range Contraction 0.00%
    Above Upper BB Strength 0.00%
    Gapped Up Strength 0.00%
    Older End-of-Day Signals for RPTX ...

       Recent Intraday Alerts

    Alert Time
    2x Volume Pace about 22 hours ago
    1.5x Volume Pace about 22 hours ago
    3x Volume Pace about 22 hours ago
    10x Volume Pace about 22 hours ago
    5x Volume Pace about 22 hours ago
    View Earlier Intraday Alerts

    Get this analysis on your stocks daily!

    Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
    Get Started for Free!
    Configure default chart indicators
    RPTX Chart by TradingView
    Basic chart:

    Profile

    Repare Therapeutics is a leading precision oncology company enabled by its proprietary synthetic lethality approach to the discovery and development of novel therapeutics. The Company utilizes its genome-wide, CRISPR-enabled SNIPRx® platform to systematically discover and develop highly targeted cancer therapies focused on genomic instability, including DNA damage repair. The Company’s pipeline includes its lead product candidate RP-3500, a potential leading ATR inhibitor, as well as CCNE1-SL inhibitor and Polθ inhibitor programs.
    Classification
    Sector: Healthcare
    Industry: Biotechnology
    Keywords: Cancer Genetics Precision Medicine Cancer Therapies Genome CRISPR Synthetic Lethality

    Is RPTX a Buy, Sell or Hold?

    Indicator Bull Case Neutral / Hold Bear Case
    50 DMA
    200 DMA
    ADX Trend
    Oversold / Overbought
    Relative Strength
    Counts: 1 bullish, 3 bearish and 1 neutral indicators. You may wish to incorporate that into your trading strategies.

    Recent News

    Date Title
    May 7 Repare Therapeutics GAAP EPS of $0.30 beats by $0.32, revenue of $52.4M beats by $14M
    May 7 Repare Therapeutics Provides Business and Clinical Update and Reports First Quarter 2024 Financial Results
    Apr 30 Repare Therapeutics & Debiopharm Announce First Patient Dosed in Phase 1/1b MYTHIC Trial Evaluating the Synthetic Lethal Combination of PKMYT1 and WEE1 Inhibition
    Apr 30 Debiopharm & Repare Therapeutics Announce First Patient Dosed in Phase 1/1b Mythic Trial Evaluating the Synthetic Lethal Combination of WEE1 AND PKMYT1 Inhibition
    Apr 26 Repare Therapeutics appoints Steven Stein to its board of directors
    Apr 26 Repare Therapeutics Appoints Steven H. Stein, M.D. to its Board of Directors
    Apr 20 Repare Therapeutics Inc.'s (NASDAQ:RPTX) market cap dropped US$21m last week; Private equity firms bore the brunt
    Mar 1 Repare Therapeutics Full Year 2023 Earnings: Misses Expectations
    Feb 28 Repare Therapeutics GAAP EPS of -$0.67 misses by $0.34, revenue of $13.05M misses by $5.88M
    Feb 28 Repare Therapeutics Inc (RPTX) Reports Financial Outcomes for Q4 and Full Year 2023
    See more RPTX news...

    Comments

    View full discussion...

    Indicators

    Indicator Value
    52 Week High 13.85
    52 Week Low 2.98
    Average Volume 198,571
    200-Day Moving Average 6.66
    50-Day Moving Average 4.45
    20-Day Moving Average 3.34
    10-Day Moving Average 3.32
    Average True Range 0.31
    RSI (14) 52.38
    ADX 38.0
    +DI 25.71
    -DI 21.90
    Chandelier Exit (Long, 3 ATRs) 3.21
    Chandelier Exit (Short, 3 ATRs) 3.91
    Upper Bollinger Bands 3.78
    Lower Bollinger Band 2.91
    Percent B (%b) 1.01
    BandWidth 26.02
    MACD Line -0.26
    MACD Signal Line -0.39
    MACD Histogram 0.1264
    Fundamentals Value
    Market Cap 159.67 Million
    Num Shares 42.1 Million
    EPS -2.31
    Price-to-Earnings (P/E) Ratio -1.64
    Price-to-Sales 6.17
    Price-to-Book 1.40
    Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
    Resistance 4 (R4) 4.39
    Resistance 3 (R3) 4.38 4.17 4.29
    Resistance 2 (R2) 4.17 4.02 4.18 4.26
    Resistance 1 (R1) 3.98 3.92 3.88 3.99 4.22
    Pivot Point 3.77 3.77 3.72 3.77 3.77
    Support 1 (S1) 3.58 3.62 3.47 3.59 3.36
    Support 2 (S2) 3.37 3.52 3.37 3.32
    Support 3 (S3) 3.18 3.37 3.29
    Support 4 (S4) 3.19